Timing and type of side effects differ greatly from chemotherapy
Fine-tuning radiation for recurrent cancers
Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival
Research supports national guidelines for early-stage breast cancer
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Multi-center study indicates benefit is associated with risk stratification and the utilization of radiation therapy
Should institutions adopt “time to treatment” as a new quality metric?
CDX-011 shows promise for triple negative disease
Latest radiation therapies for treating breast cancer may minimize exposure to the heart